CERS1 and neoplasm: The findings of our in vivo model of CBD treatment did not show survival benefit in the animals which may be indicative of the fact that CerS1 was not upregulated in the treated tumours with CBD (Fig. 8g), although in combination with chemotherapy drugs; gemcitabine and abraxane a significant tumour burden reduction was observed.